0001654541-15-000003.txt : 20151117 0001654541-15-000003.hdr.sgml : 20151117 20151117132656 ACCESSION NUMBER: 0001654541-15-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151117 DATE AS OF CHANGE: 20151117 EFFECTIVENESS DATE: 20151117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Remedy Labs, Inc. CENTRAL INDEX KEY: 0001654541 IRS NUMBER: 475055092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-248722 FILM NUMBER: 151237781 BUSINESS ADDRESS: STREET 1: 74 LYNCH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94109 BUSINESS PHONE: (650) 919-3446 MAIL ADDRESS: STREET 1: 74 LYNCH STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94109 D/A 1 primary_doc.xml X0707 D/A LIVE 0001654541 Remedy Labs, Inc. 74 LYNCH STREET SAN FRANCISCO CA CALIFORNIA 94109 (650) 919-3446 DELAWARE None None Corporation true 2015 Victor Echevarria 74 Lynch Street San Francisco CA CALIFORNIA 94109 Executive Officer Director Marija Ringwelski 74 Lynch Street San Francisco CA CALIFORNIA 94109 Executive Officer John Schulte 74 Lynch Street San Francisco CA CALIFORNIA 94109 Executive Officer Other Technology Decline to Disclose 06b true 0001654541-15-000001 2015-10-02 false true true Convertible promissory notes, including the preferred stock and common stock issuable upon conversion thereof false 0 1900000 1100000 800000 false 10 0 0 0 false Remedy Labs, Inc. Victor Echevarria Victor Echevarria Chief Executive Officer 2015-11-16